EnzymoCore
EnzymoCore is an Israeli biotechnology company that develops and licenses proprietary immobilized enzyme biocatalysts (TransZyme A, TransZyme ET, OmegaZyme ET) for enzymatic biodiesel production from low-grade feedstocks and for omega-3 EPA/DHA enrichment in nutraceuticals, serving biodiesel producers and functional-food manufacturers through joint ventures and technology licensing.
- Company typePrivate
- Founded2007
- HeadquartersShafa `amr, Israel
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What EnzymoCore does
EnzymoCore Ltd. is an Israeli private biotechnology company founded in 2007 by Dr. Sobhi Basheer (formerly co-founder of NASDAQ-listed Enzymotec) to commercialize proprietary immobilized enzyme technology for biodiesel production and omega-3 fatty acid enrichment. The company's core technology centers on methanol-resistant immobilized lipases covalently bound to specialized carriers, which catalyze esterification and transesterification simultaneously, enabling conversion of feedstocks with 0–100% free fatty acid content — including used cooking oil, brown grease, animal fats and acid oils — into ASTM and EN specification biodiesel at 99%+ conversion efficiency. Flagship products include TransZyme A (biodiesel biocatalyst), TransZyme ET and OmegaZyme ET (omega-3 EPA/DHA enrichment for nutraceuticals), all protected by 6 US patents plus additional international filings.
The company monetizes through three streams: (1) direct enzyme/biocatalyst sales priced at $150-300 per kg, (2) licensing of its proprietary enzymatic process technology to joint-venture partners who fund plant operations and feedstock procurement, and (3) engineering services delivered in partnership with Meptagon (EPCM partner, 550+ engineers). EnzymoCore operates a partnership-led go-to-market: 50:50 joint ventures with Nordtraube (Peru, 2015) and ANTAN (Germany, 2016), plus collaboration agreements with M-Energy (South Korea, 30,000 t/y), Luming Green (Shanghai pilot), Maida One (Thailand, 20,000 t/y retrofitted plant), and Zohar Dalia (Israel). Cumulative disclosed external capital is approximately $2.4 million in equity (AquAgro Fund, 2008) and roughly $985,000 in grants (BIRD-F 2009, EISMEA 2018); revenue is not publicly disclosed. The company is led by co-CEOs Dr. Sobhi Basheer and Nehemya Zamosh, with operations spanning six countries.
EnzymoCore firmographics
Firmographics- Name
- EnzymoCore
- Legal name
- EnzymoCore Ltd.
- Website
- https://enzymocore.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- EnzymoCore is an Israeli biotechnology company that develops and licenses proprietary immobilized enzyme biocatalysts (TransZyme A, TransZyme ET, OmegaZyme ET) for enzymatic biodiesel production from low-grade feedstocks and for omega-3 EPA/DHA enrichment in nutraceuticals, serving biodiesel producers and functional-food manufacturers through joint ventures and technology licensing.
- Ownership category
- akta.pro rank
EnzymoCore industry classification
Industry- Product category
- Industrial Biotechnology & Biocatalysts
- NAICS
- Fats and Oils Refining and Blending (311225)
- SIC
- Industrial Organic Chemicals (2860), Fats & Oils (2070)
- akta.pro primary industry
- Biodiesel (FAME) Production (EUAAAHAC)
- akta.pro secondary industries
- Biofuels & Renewable Fuels Switching (Biomethane/RNG, Bio-oils, Sustainable Biomass) (EUABAJAD), Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ)
Keywords
Where EnzymoCore is headquartered
LocationHeadquarters
- HQ city
- Shafa `amr
- HQ country
- Israel
- HQ region
- Middle East
Offices5 records
Markets served
EnzymoCore business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Enzyme/Biocatalyst Sales: Sale of proprietary immobilized enzyme products (TransZyme A, TransZyme ET, OmegaZyme ET) to biodiesel and functional food producers. Pricing is $150-300 per kg enzyme depending on volume.
- Technology Licensing: Licensing of proprietary enzymatic technology to joint venture partners worldwide. Partners receive rights to use patents, process technology, and receive ongoing enzyme supply.
- Engineering Services: Process design, engineering support, and technical assistance for plant setup and operation through partnership with Meptagon.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Enzyme pricing per kg |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
EnzymoCore product offering
Product offeringCore offering
EnzymoCore develops and commercializes proprietary immobilized enzyme-based biocatalysts, primarily its flagship TransZyme A lipase product, for the production of ASTM and EN specification biodiesel from low-grade feedstocks including used cooking oil, brown grease, animal fats, and high free fatty acid (0-100% FFA) materials. The company also offers TransZyme ET and OmegaZyme ET biocatalysts for omega-3 EPA and DHA enrichment in fish and algal oils for nutraceutical applications, licensing its patented technology through joint ventures and direct sales to biodiesel producers and functional food companies worldwide.
Product overview
EnzymoCore is a technology company providing immobilized enzyme-based biocatalysts for two main industries: biodiesel production and functional foods (omega-3 concentrates). The core product is TransZyme A, an immobilized lipase enzyme for biodiesel production that handles feedstocks with 0-100% free fatty acids. The company also offers HighOmega branded products including TransZyme ET and OmegaZyme ET biocatalysts for omega-3 EPA/DHA enrichment in fish and algal oils. All products are protected by multiple international patents.
Differentiator
Problem solved
Functional benefit
Brands
- TransZyme A: Flagship immobilized enzyme biocatalyst product for biodiesel production, transforming glycerides and FFAs to fatty acid methyl esters
- TransZyme ET
- OmegaZyme ET
- HighOmega
Products and services
- TransZyme A Flagship immobilized lipase enzyme biocatalyst for production of fatty acid methyl esters (biodiesel) from all types of feedstocks with 0-100% free fatty acid content, including used cooking oil, brown grease, animal fats, and acid oils. Transforms all glycerides (tri-, di-, mono-glycerides) and FFAs in presence of methanol to fatty acid methyl esters, with glycerol and water as byproducts; produces 3,000-5,000 tons of biodiesel per ton of enzyme.
- TransZyme ET Biocatalyst for production of high concentrations of EPA and DHA omega-3 fatty acids in the form of fatty acid ethyl esters from fish and algal oils, for nutraceutical and functional food applications.
- OmegaZyme ET Biocatalyst for production of high concentrations of EPA and DHA omega-3 fatty acids in glyceride form characterized by high stability and bioavailability, for nutraceutical and functional food applications.
- HighOmega Branded omega-3 fatty acid concentrate product line and dedicated website (high-omega.com) featuring EnzymoCore's proprietary enzymatic technology for producing high-concentration EPA and DHA omega-3 ingredients for the functional food industry.
- Enzymatic Biodiesel Production Technology (Technology Licensing) Licensed process technology package for enzymatic biodiesel production, providing joint venture partners with patents, process know-how, enzyme supply, and engineering support to build and operate commercial-scale biodiesel plants from second and third generation feedstocks.
Quantifiable outcome
- 3,000-5,000 tons of biodiesel produced per ton of enzyme
- +5 more outcomes
Companies that use EnzymoCore
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
EnzymoCore technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
EnzymoCore partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and secondary.
- ANTANcore50:50 joint venture with German company ANTAN for first enzyme-based Biodiesel plant in Leipzig, Germany. Strategic commercial relationship with leading company in German biodiesel industry, one of the most advanced territories with favorable regulations, tax benefits, and incentives.
- Nordtraube Perucore50:50 joint venture with Peruvian company Nordtraube in Lima/Peru for first joint enzyme-based Biodiesel plant in Peru. Joint venture combines immobilized enzyme experience with biodiesel expertise, global vision with local relevance. Technology designed for Peruvian and international markets.
- M EnergycoreCollaboration with Korean biodiesel producer M-Energy for enzymatic process development. International joint research project supported by Israeli and Korean governments. Produced 30,000 tonnes/year of ASTM biodiesel using brown grease feedstock extracted from grease trap and FOG (fat, oil, grease) materials.
- Luming GreensecondaryPilot plant operator in Shanghai/China making biodiesel from used cooking oil. Pilot plant (1.0 ton/day capacity) uses EnzymoCore immobilized enzymes as production catalysts.
- PurolitesecondaryUS company partner in BIRD-F government grant ($800,000) for commercialization of enzyme process using 2nd generation feedstocks. Purolite develops, produces, and distributes specialty resins for ion exchange, adsorbents, and catalyst applications.
- Zohar DaliasecondaryIsraeli surfactant manufacturer where EnzymoCore installed first pilot plant for enzymatic biodiesel production in November 2009. First company to use EnzymoCore's immobilized enzyme process. Uses glycerol byproduct for liquid soap production.
- MeptagoncoreStrategic engineering partner with 60 years of experience in design, plant engineering, and construction (EPCM). Meptagon provides turnkey solutions for enzymatic biodiesel plants from early design through implementation and trials. Meptagon employs 550+ people with expertise across mechanical, electrical, and process engineering disciplines.
- Appalachian BiofuelssecondaryUS joint venture partnership to produce 28 million gallons per year (MMgy) using EnzymoCore's immobilized enzyme technology in Russell County, Virginia.
- Maida OnesecondaryThai company that retrofitted from chemical to EnzymoCore's enzymatic process on commercial scale of 20,000 tonnes/year using used cooking oil (November 2012).
Scale indicators10 records
Recent moves8 records
Expansion highlights5 records
EnzymoCore competitors and assessment
Company assessmentBroad incumbents
- Novozymes (Novonesis): Global enzyme leader (now Novonesis after merger with Chr. Hansen) with broad biodiesel lipase offerings and enzyme R&D scale orders of magnitude larger than EnzymoCore. Comparable as a direct competing supplier of lipase biocatalysts to the biodiesel industry.
- DSM (now dsm-firmenich): Large life sciences and nutrition company with an enzymes business serving biofuels, animal nutrition, and food ingredients including omega-3 (veramaris). Comparable as a broad incumbent competing in both biodiesel enzymes and omega-3 concentrates.
- Enzymotec: Biofunctional lipid ingredient company (formerly NASDAQ-listed) co-founded by Dr. Sobhi Basheer, developing omega-3 and phospholipid ingredients for nutraceuticals. Highly comparable as the founder's prior platform in the same enzyme-based lipid ingredient space.
- Neste: Global leader in renewable diesel (HVO/HEFA) made from waste and residue feedstocks. Comparable as a large incumbent in renewable fuels competing for the same waste-feedstock-to-fuel mandate that EnzymoCore's enzymatic biodiesel serves.
- Archer Daniels Midland (ADM): Diversified agribusiness with biodiesel production and an omega-3 (onavita) ingredient business. Comparable as a large incumbent operating across both of EnzymoCore's biodiesel and omega-3 verticals.
- Renewable Energy Group (now part of Chevron): One of North America's largest biodiesel producers, now part of Chevron, operating plants using multiple feedstock pathways. Comparable as a large incumbent biodiesel producer that could be a customer or competitor for enzyme technology.
Direct peers
- AB Enzymes (ABF Ingredients): Specialty industrial enzyme manufacturer offering esterification and biodiesel enzyme products. Direct competitor to TransZyme A in the immobilized-lipase-for-biodiesel niche.
- Codexis: Engineered enzyme company with biodiesel and other industrial biocatalyst programs, using directed evolution to design lipases. Comparable as a technology-driven enzyme developer serving fuels and industrial chemistry customers.
Others
- Purolite (Ecolab): Specialty resin and carrier supplier for immobilized enzymes, and EnzymoCore's BIRD-F grant partner. Comparable as the enabling carrier/adsorbent vendor whose materials support EnzymoCore's immobilized enzyme products.
Regional players
- Verbio: German biodiesel and bioethanol producer with enzymatic biodiesel operations comparable to EnzymoCore's German JV with ANTAN. Comparable as a European regional player in the same biodiesel value chain.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
EnzymoCore financial estimates
Financial estimateRevenue estimate
Valuation estimate
EnzymoCore leadership team
Management profileNumber of profiles
Profiles10 records
EnzymoCore subsidiaries and ownership
Company hierarchySubsidiaries2 records
EnzymoCore funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EnzymoCore M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EnzymoCore
What does EnzymoCore do?
EnzymoCore develops and commercializes proprietary immobilized enzyme-based biocatalysts, primarily its flagship TransZyme A lipase product, for the production of ASTM and EN specification biodiesel from low-grade feedstocks including used cooking oil, brown grease, animal fats, and high free fatty acid (0-100% FFA) materials. The company also offers TransZyme ET and OmegaZyme ET biocatalysts for omega-3 EPA and DHA enrichment in fish and algal oils for nutraceutical applications, licensing its patented technology through joint ventures and direct sales to biodiesel producers and functional food companies worldwide.
Is EnzymoCore a public or private company?
EnzymoCore is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was EnzymoCore founded?
EnzymoCore was founded in 2007. It employs 1 to 10 people.
Where is EnzymoCore based?
EnzymoCore is headquartered in Shafa `amr, Israel, in the Middle East region.
How does EnzymoCore make money?
Three revenue lines are on record. Enzyme/Biocatalyst Sales are the primary driver. The others are technology Licensing and engineering Services.
Who are EnzymoCore's main competitors?
Broad incumbents on record are Novozymes (Novonesis), DSM (now dsm-firmenich), Enzymotec, Neste, Archer Daniels Midland (ADM) and Renewable Energy Group (now part of Chevron). Direct peers are AB Enzymes (ABF Ingredients) and Codexis. Purolite (Ecolab) is listed as an others. Verbio is listed as a regional player.
Does EnzymoCore have an API?
No public API is recorded for EnzymoCore.
What industry is EnzymoCore in?
EnzymoCore's product category is Industrial Biotechnology & Biocatalysts. Its primary akta.pro industry code is EUAAAHAC, Biodiesel (FAME) Production, with a secondary code of EUABAJAD, Biofuels & Renewable Fuels Switching (Biomethane/RNG, Bio-oils, Sustainable Biomass). Its NAICS code is 311225 and its SIC code is 2860.